Early treatment includes growth hormone (GH), which not only improves height and body composition (reduces body fat and increases muscle mass) but also decreases morbidity and mortality associated with obesity-related complications. The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.